<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_CSBJ1857 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEgr5 jpg ?>
<?FILEgr6 jpg ?>
<?FILEgr7 jpg ?>
<?FILEgr8 jpg ?>
<?FILEgr9 jpg ?>
<?FILEgr10 jpg ?>
<?FILEgr11 jpg ?>
<?FILEgr12 jpg ?>
<?FILEgr13 jpg ?>
<?FILEfx1 jpg ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Comput Struct Biotechnol J</journal-id>
    <journal-id journal-id-type="iso-abbrev">Comput Struct Biotechnol J</journal-id>
    <journal-title-group>
      <journal-title>Computational and Structural Biotechnology Journal</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2001-0370</issn>
    <publisher>
      <publisher-name>Research Network of Computational and Structural Biotechnology</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9678803</article-id>
    <article-id pub-id-type="pii">S2001-0370(22)00502-5</article-id>
    <article-id pub-id-type="doi">10.1016/j.csbj.2022.11.009</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SoluProtMut<sup>DB</sup>: A manually curated database of protein solubility changes upon mutations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au005">
        <name>
          <surname>Velecký</surname>
          <given-names>Jan</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
      </contrib>
      <contrib contrib-type="author" id="au010">
        <name>
          <surname>Hamsikova</surname>
          <given-names>Marie</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au015">
        <name>
          <surname>Stourac</surname>
          <given-names>Jan</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au020">
        <name>
          <surname>Musil</surname>
          <given-names>Milos</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af015" ref-type="aff">c</xref>
      </contrib>
      <contrib contrib-type="author" id="au025">
        <name>
          <surname>Damborsky</surname>
          <given-names>Jiri</given-names>
        </name>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au030">
        <name>
          <surname>Bednar</surname>
          <given-names>David</given-names>
        </name>
        <email>222755@mail.muni.cz</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <contrib contrib-type="author" id="au035">
        <name>
          <surname>Mazurenko</surname>
          <given-names>Stanislav</given-names>
        </name>
        <email>mazurenko@mail.muni.cz</email>
        <xref rid="af005" ref-type="aff">a</xref>
        <xref rid="af010" ref-type="aff">b</xref>
        <xref rid="cor1" ref-type="corresp">⁎</xref>
      </contrib>
      <aff id="af005"><label>a</label>Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno 61137, Czech Republic</aff>
      <aff id="af010"><label>b</label>International Clinical Research Center, St. Anne’s University Hospital Brno, Pekarska 53, Brno 65691, Czech Republic</aff>
      <aff id="af015"><label>c</label>Department of Information Systems, Faculty of Information Technology, Brno University of Technology, Bozetechova 2, Brno 61200, Czech Republic</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>⁎</label>Corresponding authors at: Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno 61137, Czech Republic. <email>222755@mail.muni.cz</email><email>mazurenko@mail.muni.cz</email></corresp>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>09</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>09</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>20</volume>
    <fpage>6339</fpage>
    <lpage>6347</lpage>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>4</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>4</day>
        <month>11</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Author(s)</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract abstract-type="author-highlights" id="ab005">
      <title>Highlights</title>
      <p>
        <list list-type="simple" id="l0005">
          <list-item id="u0005">
            <label>•</label>
            <p id="p0215">Solubility is a fundamental characteristic of any protein and an essential factor in its production, yet not well predictable.</p>
          </list-item>
          <list-item id="u0010">
            <label>•</label>
            <p id="p0220">SoluProtMut<sup>DB</sup> is the first protein database of mutational solubility data with ∼33 000 entries available for machine learning.</p>
          </list-item>
          <list-item id="u0015">
            <label>•</label>
            <p id="p0225">The data are manually curated against the source literature and cross-linked to other biological databases.</p>
          </list-item>
          <list-item id="u0020">
            <label>•</label>
            <p id="p0230">A modern user-friendly web interface following the FAIR principles allows browsing and searching the database online.</p>
          </list-item>
          <list-item id="u0025">
            <label>•</label>
            <p id="p0235">The database may serve for reporting negative results from solubilization experiments, thus improving solubility predictors.</p>
          </list-item>
        </list>
      </p>
    </abstract>
    <abstract id="ab010">
      <p>Protein solubility is an attractive engineering target primarily due to its relation to yields in protein production and manufacturing. Moreover, better knowledge of the mutational effects on protein solubility could connect several serious human diseases with protein aggregation. However, we have limited understanding of the protein structural determinants of solubility, and the available data have mostly been scattered in the literature. Here, we present SoluProtMut<sup>DB</sup> – the first database containing data on protein solubility changes upon mutations. Our database accommodates 33 000 measurements of 17 000 protein variants in 103 different proteins. The database can serve as an essential source of information for the researchers designing improved protein variants or those developing machine learning tools to predict the effects of mutations on solubility. The database comprises all the previously published solubility datasets and thousands of new data points from recent publications, including deep mutational scanning experiments. Moreover, it features many available experimental conditions known to affect protein solubility. The datasets have been manually curated with substantial corrections, improving suitability for machine learning applications. The database is available at loschmidt.chemi.muni.cz/soluprotmutdb.</p>
    </abstract>
    <kwd-group id="kg005">
      <title>Keywords</title>
      <kwd>Mutational database</kwd>
      <kwd>Protein engineering</kwd>
      <kwd>Soluble expression</kwd>
      <kwd>Protein yield</kwd>
      <kwd>Machine learning</kwd>
      <kwd>Protein aggregation</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="s0005">
    <label>1</label>
    <title>Introduction</title>
    <p id="p0005">Protein mutational databases accumulate results from experiments examining how mutations introduced to a protein affect a selected property. Several such databases have arisen recently, including FireProt<sup>DB</sup>
<xref rid="b0005" ref-type="bibr">[1]</xref> for the protein stability data for single-point mutants, the MPTherm <xref rid="b0010" ref-type="bibr">[2]</xref> database for membrane protein thermodynamics, or D3DistalMutation <xref rid="b0015" ref-type="bibr">[3]</xref> for enzyme activity. However, there has not been any mutational solubility database yet despite solubility being a basic characteristic of any globular protein. Moreover, high solubility is essential for high-dosing protein therapeutics or for efficient protein production <xref rid="b0020" ref-type="bibr">[4]</xref>, <xref rid="b0025" ref-type="bibr">[5]</xref>. The lowered solubility of a body protein due to a mutation may also cause a disease <xref rid="b0030" ref-type="bibr">[6]</xref>. And neither too low nor too high solubility is required for successful structure determination of a protein in the crystalline form.</p>
    <p id="p0010">Prediction of solubility change upon mutation is thus an important problem. Several predictors for this task were developed, usually using mutational solubility data sets for training collected independently from the literature <xref rid="b0035" ref-type="bibr">[7]</xref>, <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0050" ref-type="bibr">[10]</xref>. While these attempts showed great promise, the training datasets were rather limited in the number of entries and their annotations. These limitations provide a possible explanation as to why recent studies comparing the predictors revealed significant room for improvement, as the latest predictors did not exceed the correct prediction ratio of 70% <xref rid="b0050" ref-type="bibr">[10]</xref>, <xref rid="b0055" ref-type="bibr">[11]</xref>.</p>
    <p id="p0015">The data available in the solubility datasets come mostly from small-scale experiments. These often search for a solubilizing mutation to a particular protein in order to enhance its insufficient solubility. A small-scale experiment measures only a small number of mutants and only one direction of solubility change is often observed among all of them. Another drawback is that these experiments may be incomparable due to the different conditions under which they were conducted. Most typically, a variant of an electrophoresis assay and protein staining is used to assess protein solubility through mass separation, e.g., the SDS–PAGE assay. Other, less frequent methods include Western blotting, where the soluble fraction of protein of interest is separated and marked via antigen binding.</p>
    <p id="p0020">In contrast, high-throughput experiments provide many results from a single run. Apart from the clear advantage of obtaining a large amount of data at once, they allow a more precise comparison thanks to the elimination of setup differences. High-throughput methods typically measure solubility indirectly through another property, e.g., fluorescence, which can be achieved in an automated manner more easily. For instance, in recent studies by Whitehead’s group <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>, fluorescence-activated cell sorting (FACS) was used to select solubilizing mutations out of almost all possible single-point variants. While such a strategy is usually applied to one protein at a time, it has the potential to provide the sufficient data abundance for modern data-hungry machine learning (ML) methods <xref rid="b0070" ref-type="bibr">[14]</xref>.</p>
    <p id="p0025">Here we present a database incorporating solubility data from several sources (<xref rid="f0005" ref-type="fig">Fig. 1</xref>): (i) curated data from OptSolMut <xref rid="b0035" ref-type="bibr">[7]</xref>, CamSol <xref rid="b0040" ref-type="bibr">[8]</xref>, A3D <xref rid="b0045" ref-type="bibr">[9]</xref> and PON-Sol <xref rid="b0050" ref-type="bibr">[10]</xref> datasets, (ii) recently conducted deep mutational scanning (DMS) of solubility at Whitehead’s research group <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>, (iii) our own literature search for solubility experiments, and (iv) data from high-throughput experiments currently conducted in our laboratories.<fig id="f0005"><label>Fig. 1</label><caption><p>The data sources of SoluProtMut<sup>DB</sup> and their processing. The primary sources are the merged data from the earlier published datasets of protein-solubility predictors and the high-throughput data from Whitehead’s group <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>. The datasets have been manually checked with the original publications and corrected accordingly. Apart from these, we conducted an extensive literature search and deposited more recently published data and the data collected in our laboratories. The information about a dataset membership and UniProt <xref rid="b0075" ref-type="bibr">[15]</xref> and HotSpot Wizard 3.0 <xref rid="b0080" ref-type="bibr">[16]</xref> annotations were added to the entries.</p></caption><graphic xlink:href="gr1"/></fig></p>
    <p id="p0030">The database goes beyond the basic reporting of introduced mutations and their effects on protein solubility. We performed an extensive manual curation of each entry based on the original publications. We also keep track of the experimental setup wherever possible as it has a major influence on the experimental outcome <xref rid="b0085" ref-type="bibr">[17]</xref>. This setup has two main components: expression-related conditions (how the protein was produced) and assay-related conditions (how the solubility was measured). For instance, the expression conditions include host cells, the temperature, and induction times used. Assays differ mainly in the physical property used to measure solubility change. Finally, the data are annotated with dataset memberships, links to UniProt <xref rid="b0075" ref-type="bibr">[15]</xref> and its annotations, and HotSpot Wizard <xref rid="b0080" ref-type="bibr">[16]</xref> features per sequence or structure as depicted in <xref rid="f0005" ref-type="fig">Fig. 1</xref>.</p>
    <p id="p0035">While the database will serve as a valuable source of insights for protein engineers, structural biologists, or biochemists, we have made our database convenient for the broad ML and data science communities as well, e.g., to facilitate using the deposited data in the development and testing of predictive models. All the aforementioned experimental conditions and annotations are utilizable as features. We also performed a systematization of reported changes and created a flexible Export Wizard. The systematization deals with the verbally-assessed changes – these are discrete and inexact values with no scale specified by the authors. Export Wizard allows exporting the filtered data and converting the values to the desired classes to be used in a target model.</p>
    <p id="p0040">With the advent of high-throughput screening methods, we may see a flood of mutational solubility data published, and SoluProtMut<sup>DB</sup> should serve as a central depository for this type of data. A centralized and regularly updated depository for mutational solubility data will facilitate the <italic>in silico</italic> engineering of protein solubility, which is critical in biopharmacy, biotechnology, or structural biology. The depository will also be useful for data scientists, ML engineers, protein engineers and medical doctors.</p>
  </sec>
  <sec id="s0010">
    <label>2</label>
    <title>Materials and methods</title>
    <sec id="s0015">
      <label>2.1</label>
      <title>Data from small-scale experiments</title>
      <p id="p0045">The cornerstones of SoluProtMut<sup>DB</sup> are four mutational solubility datasets, published between 2010 and 2017, which we merged together: OptSolMut <xref rid="b0035" ref-type="bibr">[7]</xref>, CamSol <xref rid="b0040" ref-type="bibr">[8]</xref>, A3D <xref rid="b0045" ref-type="bibr">[9]</xref>, and PON-Sol <xref rid="b0050" ref-type="bibr">[10]</xref>. Every datapoint in each of these datasets represents a mutated variant of a particular protein, where the protein is specified either by its sequence or Protein Data Bank ID (PDB ID) and labeled according to the effect on the protein solubility. While none of the datasets is fully contained in another, they do overlap significantly. Therefore, we ensured that each datapoint is contained in the final database only once and assigned to all the datasets it appears in. We also added new data from the updated PON-Sol dataset <xref rid="b0055" ref-type="bibr">[11]</xref>. Furthermore, as all these datasets only comprise the solubility data from publications before 2017, we conducted a data search in more recent literature and added new results.</p>
      <p id="p0050">We carried out manual validation and curation of the datasets against the source publications as the data are not in a machine-readable format in most of the source publications. We found and resolved a substantial number of discrepancies of the following types by correction or removal of the affected datapoints: reports of changes in properties with no clear relation to solubility; measurements which are not present in the source publication; wrong values; wrong positions or residues of substitutions.</p>
      <p id="p0055">During the manual processing of the publications, we additionally extracted the data that do not appear in the published datasets. These include reported experimental conditions, such as measurement assay, host organism and strain, temperature, pH, and concentration method used; originally reported numerical changes in solubility; and even more than hundred instances of measured protein variants that were left unnoticed by the authors of the datasets. We also distinguish the types of solubility the continuous values referred to: the soluble fraction, soluble concentration, or total concentration.</p>
      <p id="p0060">During the validation, we assigned a UniProt accession number (UniProt AC) of an original variant to every datapoint and renumbered the mutated positions with respect to the UniProt sequence. This was necessary as the proteins in the datasets are only assigned with PDB IDs or protein/gene names, which are, however, less reliable, stable, or not unique in comparison to UniProt ACs in the long term. In the case of PDBs, one structure can refer to several proteins, and a single protein typically has multiple relevant PDBs with new and refined structures of proteins appearing over time.</p>
    </sec>
    <sec id="s0020">
      <label>2.2</label>
      <title>Deep mutational scanning data</title>
      <p id="p0065">The eminent source is the data collected at Whitehead’s research group – the first use of DMS for solubility screening. The group measured the soluble expression of the levoglucosan kinase, TEM-1 <inline-formula><mml:math id="M1" altimg="si4.svg"><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:math></inline-formula>-lactamase, and pyrrolidine ketide synthase variants in <italic>E.</italic> <italic>coli</italic> or yeast assays <xref rid="b0060" ref-type="bibr">[12]</xref>, <xref rid="b0065" ref-type="bibr">[13]</xref>. Their DMS approach consisted of three steps. The first step was comprehensive saturation mutagenesis across the entire protein, which yielded a cell library of all possible single-point mutants. The second step was the selection of cells with soluble protein. And the third step was deep sequencing – measuring the frequencies of the variants before and after the selection procedure of the second step by sampling and sequencing them. The authors explored two selection procedures: Tat-export and FACS. In the former, soluble protein provided antibiotic resistance and was required for cell survival. In the latter, the fluorescence change upon binding with a fluorescence-enabled antibody or a green-fluorescence-protein (GFP) tag was exploited as the proxy to protein solubility, and then the cells with higher solubility were sorted out using FACS. The enrichment ratio for each variant was calculated based on the number of reads before and after the selection, normalized, and reported as the score for the effect of the mutations on protein solubility.</p>
      <p id="p0070">To make these continuous scores comparable with the discrete values reported in the other literature, we binned them into 5 levels according to the threshold of <inline-formula><mml:math id="M2" altimg="si5.svg"><mml:mrow><mml:mn>0.15</mml:mn></mml:mrow></mml:math></inline-formula>, suggested by the authors (that is <inline-formula><mml:math id="M3" altimg="si6.svg"><mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:mn>10</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> on a linear scale) to label enhancing mutations, and a threshold of <inline-formula><mml:math id="M4" altimg="si7.svg"><mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:mn>50</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> for significantly enhancing mutations. Symmetrically, we used <inline-formula><mml:math id="M5" altimg="si8.svg"><mml:mrow><mml:mo linebreak="badbreak">-</mml:mo><mml:mn>10</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M6" altimg="si9.svg"><mml:mrow><mml:mo linebreak="badbreak">-</mml:mo><mml:mn>33</mml:mn><mml:mo>.</mml:mo><mml:mover accent="true"><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo stretchy="true">‾</mml:mo></mml:mrow></mml:mover><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> to label slightly and significantly deteriorating mutations, respectively. The remaining datapoints were binned into the neutral class. During this process, we also omitted the scores of nonsense mutations and those having statistically insignificant enrichment values due to the low number of reads.</p>
    </sec>
    <sec id="s0025">
      <label>2.3</label>
      <title>In-house data</title>
      <p id="p0075">In addition to the published literature, the database contains the data from medium-throughput experiments on haloalkane dehalogenase, recently conducted by our research group <xref rid="b0090" ref-type="bibr">[18]</xref>.<xref rid="fn1" ref-type="fn">1</xref> Our assay, validated by comparison with SDS–PAGE on multiple proteins, measures solubility through fluorescence activity introduced by the split-GFP approach. The mutant library was created with error-prone PCR, and randomly selected mutants were measured and sequenced. Measuring was conducted in replicates, and the mutants with statistically insignificant results were discarded. This resulted in 22 datapoints available in the database.</p>
    </sec>
    <sec id="s0030">
      <label>2.4</label>
      <title>Systematization of values</title>
      <p id="p0080">By analyzing the literature, we identified five patterns appearing in solubility experiments for a mutation effect assessment. We systematized these patterns into reporting systems as per <xref rid="t0005" ref-type="table">Table 1</xref> to make the reported changes comparable even when they come from different publications and are described in different terms. These differences are partially due to the use of various assays as their precision varies, and sometimes the effect was not quantifiable. In other cases, incomplete information was published. For example, in experiments aiming to solubilize a particular protein, only verbal assessment is often reported for mutants not improving solubility.<table-wrap position="float" id="t0005"><label>Table 1</label><caption><p>The comparison table between reported solubility changes in various reporting systems. The considered reporting systems (columns) consist of 2 to 5 possible values of measured effects on solubility (rows), spanning from –– (significantly deteriorating) over neutral (N) to ++ (significantly enhancing). For example, a substantial deteriorating change in solubility could be reported as simply deteriorating in the 2- or 3-value systems or non-enhancing in the unipolar system.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td><inline-graphic xlink:href="fx1.gif"/></td></tr></tbody></table></table-wrap></p>
      <p id="p0085">We distinguish the orientation (positive, negative, or neutral) of an effect and, whenever applicable, also its significance (slight or significant). Altogether, up to five discrete values are defined: <italic>significantly/slightly deteriorating</italic>, <italic>neutral,</italic> and <italic>slightly/significantly enhancing</italic>. This system suggests different resolutions in different experiments, e.g., a value from the 5-value system should be more precise than from the 3-value system. Hence, if one mutation is enhancing in the 3-value system and another is slightly enhancing in the 5-value system, we can assume the former to be at least as enhancing as the latter, and possibly substantially more.</p>
    </sec>
    <sec id="s0035">
      <label>2.5</label>
      <title>Annotations</title>
      <p id="p0090">In addition to the data extracted from the literature, we annotated proteins on sequence and structure levels. As all the sequences were mapped to UniProt through their accession numbers, we extracted protein names, species of origin, InterPro families, and Enzyme Commission numbers from there. We also manually linked proteins with their structures in PDB. We prioritized the X-ray crystallographic structures with the highest resolution, without ligands or mutations. The assigned structures were then used as an input to HotSpot Wizard (HSW) <xref rid="b0095" ref-type="bibr">[19]</xref> to obtain additional sequence and structural features.</p>
      <p id="p0095">HSW sequence features come from multiple sequence alignment of homologous sequences. HSW obtains these sequences by a BLAST search <xref rid="b0100" ref-type="bibr">[20]</xref> against the UniRef90 database <xref rid="b0105" ref-type="bibr">[21]</xref> and clusters them using the UCLUST algorithm <xref rid="b0110" ref-type="bibr">[22]</xref> with a 90% sequence identity. Sorted by the coverage of the BLAST query, the top 200 cluster-representing sequences are selected and subsequently aligned using Clustal Omega <xref rid="b0115" ref-type="bibr">[23]</xref>. The resulting alignment is then employed (i) to estimate the conservation score for each position using the Jensen-Shannon divergence <xref rid="b0120" ref-type="bibr">[24]</xref>, (ii) to identify correlated positions using the consensus prediction of several tools integrated with HSW, and (iii) to identify potential back-to-consensus mutations, i.e., the positions in the multiple sequence alignment where an amino acid in the query sequence differs from the majority of amino acids at conserved positions.</p>
      <p id="p0100">Apart from sequence features, the following structural features are included: (i) the protein secondary structure calculated by DSSP <xref rid="b0125" ref-type="bibr">[25]</xref>, (ii) the accessible surface area calculated with the Shrake and Rupley algorithm <xref rid="b0130" ref-type="bibr">[26]</xref>, (iii) average B-factors for protein residues <xref rid="b0135" ref-type="bibr">[27]</xref>, (iv) protein pockets identified by the fpocket tool <xref rid="b0140" ref-type="bibr">[28]</xref>, and (v) protein tunnels and their bottlenecks calculated by CAVER <xref rid="b0145" ref-type="bibr">[29]</xref>. Only the tunnels connected with catalytic pockets are stored in the database. The structural features are mapped back onto UniProt sequences using the SIFTS database <xref rid="b0150" ref-type="bibr">[30]</xref>.</p>
    </sec>
    <sec id="s0040">
      <label>2.6</label>
      <title>Database structure</title>
      <p id="p0105">Measurement results of differential solubility experiments are at the core of our database. Each result is linked to a protein variant defined by a particular protein and a set of substitutions in its sequence. The effect of any protein variant on solubility contains a difference in the measured property compared to the original protein variant, both measured under the same experimental setup. This setup includes the host cell, assay, or temperature used and is linked to the corresponding results. The corresponding protein is identified by UniProt AC, and the mutated positions are based on the UniProt indexing. Each result has its alphanumerical <italic>accession code</italic>, which is meant to be stable, searchable, and therefore citable. In addition, each result may be linked to one or more published datasets.</p>
    </sec>
  </sec>
  <sec id="s0045">
    <label>3</label>
    <title>Results</title>
    <p id="p0110">The basic statistics summarizing the content of the database are given in <xref rid="t0010" ref-type="table">Table 2</xref>. The total number of datapoints consists of (i) merged 764 (610 unique) datapoints from the previously published datasets, (ii) Whitehead’s DMS data – accounting for 32 081 of the datapoints, (iii) 279 new measurements from the literature and (iv) 22 measurements carried out in-house.<table-wrap position="float" id="t0010"><label>Table 2</label><caption><p>Current statistics of the database. The most recent numbers are available at loschmidt.chemi.muni.cz/soluprotmutdb as the database is regularly updated with new data.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Datapoints</td><td align="right">32 992</td></tr><tr><td>Mutant variants</td><td align="right">17 392</td></tr><tr><td> of which multi-point</td><td align="right">157</td></tr><tr><td>Publications</td><td align="right">110</td></tr><tr><td>Proteins</td><td align="right">103</td></tr></tbody></table></table-wrap></p>
    <p id="p0115">The data reveal that a random mutation likely has a desolubilizing effect, as shown in the mutational effect distribution in <xref rid="f0010" ref-type="fig">Fig. 2</xref>. Only <inline-formula><mml:math id="M7" altimg="si10.svg"><mml:mrow><mml:mn>18</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of mutants increase solubility and just one third of them significantly. This is confirmed when the distribution is plotted per protein (<xref rid="f0015" ref-type="fig">Fig. 3</xref>). The three most frequent proteins from small-scale experiments, on the other hand, display a strong distribution bias compared to the DMS data and the ‘Other’ category alike. The exact ratio is protein-dependent.<fig id="f0010"><label>Fig. 2</label><caption><p>The distribution of protein variants in the database by their mutational effects on solubility. The distribution is divided into 5 levels: neutral (N), slightly/significantly desolubilizing (−<bold>/</bold>−−) and solubilizing (<bold><italic>+/++</italic></bold>). Notably, two thirds of the mutants show a deteriorating effect.</p></caption><graphic xlink:href="gr2"/></fig><fig id="f0015"><label>Fig. 3</label><caption><p>The six most represented proteins in the database by their entry counts. The data for the first three proteins come from deep mutational scanning experiments. The ‘Other’ category contains the remaining 97 proteins. The horizontal axis has a logarithmic scale, and the pie charts on the right display mutational effect distribution per category with the same color coding as in <xref rid="f0010" ref-type="fig">Fig. 2</xref>: neutral, desolubilizing and solubilizing mutations.</p></caption><graphic xlink:href="gr3"/></fig></p>
    <p id="p0120">While the database size is several orders of magnitude larger than the sizes of the prior datasets, the results from the high-throughput experiments from Whitehead’s group dominate the deposited data. The exhaustiveness of Whitehead’s data provides the database with great variability in mutated positions and in combinations of substituted and target amino-acid pairs (<xref rid="f0020" ref-type="fig">Fig. 4</xref>) but is limited to only three proteins. The protein variability of the database is provided by the rest of the data - <xref rid="f0015" ref-type="fig">Fig. 3</xref> contrasts the entry counts for these three proteins with the remaining ones.<fig id="f0020"><label>Fig. 4</label><caption><p>A matrix showing the numbers of mutation occurrences in the database ‘from’ (rows) and ‘to’ (columns) specific amino acids. The <inline-formula><mml:math id="M8" altimg="si1.svg"><mml:mrow><mml:mi mathvariant="normal">Σ</mml:mi></mml:mrow></mml:math></inline-formula> column and row represent sums of mutations ‘from’ and ‘to’ given amino acids, respectively. A cell color saturation shows the abundance of the corresponding combination.</p></caption><graphic xlink:href="gr4"/></fig></p>
    <p id="p0125">We kept the FAIR principles (Findable, Accessible, Interoperable, Reusable) <xref rid="b0155" ref-type="bibr">[31]</xref> in mind during the database development. In addition to making the data accessible and searchable online (see the <xref rid="s0050" ref-type="sec">section 3.1</xref>) and exportable in a machine-readable format (see the <xref rid="s0055" ref-type="sec">section 3.2</xref>), we also assigned a unique <italic>accession code</italic> (SPMDB AC) to each entry of a measurement result. The accession code is an identifier that is stable in time and can be used for searching or linking. Our database crosslinks SPMDB AC with UniProt, PDB, and InterPro databases.</p>
    <sec id="s0050">
      <label>3.1</label>
      <title>Interface</title>
      <p id="p0130">SoluProtMut<sup>DB</sup> has a user-friendly web interface enabling its users to browse, search, and export the data. The ‘Show all’ option in the navigation bar leads to the result table listing all the entries available in the database (<xref rid="f0025" ref-type="fig">Fig. 5</xref>). To filter these entries, the search at the top of the page can be used in two ways: (i) a full-text search by protein names, UniProt accession codes, PDB identifiers, InterPro entries, EC numbers, publications, dataset names, organisms, host cells, or SPMDB AC; or (ii) an advanced search capable of combining several queries on database fields (<xref rid="f0030" ref-type="fig">Fig. 6</xref>). The displayed data in the search results can be exported using Export Wizard by clicking the ‘Export’ button (see the <xref rid="s0055" ref-type="sec">section 3.2</xref>).<fig id="f0025"><label>Fig. 5</label><caption><p>An example of a result table. For clarity, only the most important columns are displayed by default: protein names, curation flags, mutations, solubility effects, and host cells. The table is paginated to avoid performance issues. A solubility effect graphic depicts both an effect and a value system provided in <xref rid="t0005" ref-type="table">Table 1</xref>. The binning system is given by the number of circles, whereas the effect is given by one of the signs: <bold>orange minus (</bold>−<bold>)</bold> for deteriorating, black tilde (<inline-formula><mml:math id="M9" altimg="si2.svg"><mml:mrow><mml:mo>∼</mml:mo></mml:mrow></mml:math></inline-formula>) for neutral and <bold><italic>blue plus (+)</italic></bold> for enha.ncing mutations.</p></caption><graphic xlink:href="gr5"/></fig><fig id="f0030"><label>Fig. 6</label><caption><p>The advanced search with an example of a filtering protocol. In this example, the database will find measurements from OptSolMut and PON-Sol datasets with enhancing or deteriorating solubility effect.</p></caption><graphic xlink:href="gr6"/></fig></p>
      <p id="p0135">Protein and variant pages can be accessed from the result table by clicking on a protein name or mutation, respectively. A variant page shows all measurements for the particular protein variant. A protein page shows basic information about the protein, such as UniProt AC, species, EC number, assigned InterPro families, or the table containing experimental data for this protein. In addition, interactive ProtVista tracks <xref rid="b0160" ref-type="bibr">[32]</xref> visualize the following sequence features: the secondary structure, catalytic sites, natural variants, amino-acid charges, catalytic pockets, tunnels, B-factors, conservation, and back-to-consensus mutations. The structure, if available, is shown using the Mol* viewer <xref rid="b0165" ref-type="bibr">[33]</xref> (<xref rid="f0035" ref-type="fig">Fig. 7</xref>). Mutated positions can be highlighted in the structure by clicking on the eye icons in the data table.<fig id="f0035"><label>Fig. 7</label><caption><p>The visualization of mutations in a protein with a known 3D structure. User-selected mutations can be highlighted in the structure. In this example, the mutated positions resulting in a significant change in solubility are highlighted in yellow.</p></caption><graphic xlink:href="gr7"/></fig></p>
      <p id="p0140">The Datasets page lists the known mutational solubility datasets. Further details, including the authors and the links to the publication and the raw dataset, can be obtained by clicking on a dataset name. Furthermore, the dataset page contains statistics on the overall distribution of solubility effects in each dataset and the similarity to the other datasets.</p>
    </sec>
    <sec id="s0055">
      <label>3.2</label>
      <title>Data export</title>
      <p id="p0145">The complete database can be downloaded as a MariaDB database server dump in the SQL format. In addition to this option, we developed Export Wizard for user-friendly exporting a currently browsed subset of the database, e.g., defined by the active search filter, as a tabular dataset in the CSV format. This functionality is specifically aimed at data scientists and machine learning developers to allow them to analyze or use the data with minimum processing effort. Optionally, additional filtering/labeling and data augmentation may be applied before data export.</p>
      <p id="p0150">The filtering also allows selecting only the results measured in continuous values, suitable for a regression analysis and modeling. The alternative is the labeling that adapts the data to a specific model according to the number of bins distinguished by effects on solubility: after selecting a model from <xref rid="t0005" ref-type="table">Table 1</xref>, each exported datapoint is assigned a label from that system. If a reported effect is not present in the selected system, it is either converted to a partially compatible label or dropped. The process may be adjusted by selecting one of the abundance, reliability, or compromise modes. The first option converts as many values as possible; the second option leaves out all incompatible values; and the third option compromises on the significance, i.e., all converted labels are marked defensively as a slight change. Users can display the active conversion table by clicking ‘See details’. The user interface for this step is shown in <xref rid="f0065" ref-type="fig">Fig. A.6</xref>.</p>
      <p id="p0155">Finally, in the case of ML-dataset creation, users may want to use the data-augmentation (data-symmetrization) function, which adds the reverse mutations to the dataset, i.e., datapoints with substituted and target residues swapped and inverse solubility effects. This will resolve the likely problem of the imbalance between the counts of deteriorating and enhancing mutations (<xref rid="f0010" ref-type="fig">Fig. 2</xref>), which has often been reported to decrease the performance of predictors for other mutational data types <xref rid="b0170" ref-type="bibr">[34]</xref>, <xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0180" ref-type="bibr">[36]</xref>.</p>
    </sec>
  </sec>
  <sec id="s0060">
    <label>4</label>
    <title>Discussion</title>
    <p id="p0160">SoluProtMut<sup>DB</sup> is the first mutational database of solubility data and is ready to serve as a central depository for data from mutagenesis experiments targeting protein solubility. To date, our database contains almost 33 000 experimental results of solubility effects upon mutations, thereby representing an essential digital resource for this type of data. The database comprises the previously published datasets and new data from the more recent literature. We have improved the reliability of these datasets by manual curation and overlap checks. We examined over a hundred original publications from which the data were gathered, including a few studies that produced hundreds to thousands of datapoints each, thanks to the use of such high-throughput experimental techniques as FACS. Lastly, we deposited the solubility data measured in our group. We will maintain the database, add new data, and continue with the curation process.</p>
    <p id="p0165">We believe the database is of great value for data scientists and will help to understand the mechanisms controlling solubility. With this in mind, we also focused on the ML potential of the database by making our database friendly for the ML community: (i) we ensured the data are reliable; (ii) we systematized the solubility effects reported in the literature to be easily understood by the experts outside biology; and (iii) we created Export Wizard to facilitate adaptation of the data for ready-made ML models. As a result, we expect that the user-friendly web interface and the other steps taken will broaden the audience and user community. The data can now be analyzed or modeled, even without a deep understanding of the underlying technical or biological details.</p>
    <p id="p0170">Thanks to the new data published in recent years, the database is an order of magnitude larger than an average solubility dataset. This abundance comes from recent high-throughput experiments, generating a more realistic distribution of target amino acids and observed effects compared to the previous datasets owing to the possibility of covering all possible single-point mutants.</p>
    <p id="p0175">Specifically, the DMS experiments manifest their strength as they show no extreme per-protein deviation of the effect distribution (<xref rid="f0015" ref-type="fig">Fig. 3</xref>) from the overall distribution (<xref rid="f0010" ref-type="fig">Fig. 2</xref>), which is of particular importance for ML applications. The DMS data are highly representative as they lack a selection bias in introduced mutations (<xref rid="f0050" ref-type="fig">Fig. A.3</xref>). Moreover, the substituted amino acids in the database follow the distribution of amino acids seen in nature (<xref rid="f0045" ref-type="fig">Fig. A.2</xref>). In contrast, the selection bias is apparent in the small-scale experiments, even when all their data are merged (<xref rid="f0055" ref-type="fig">Fig. A.4</xref>). In terms of effect distribution, the DMS data display more desolubilizing mutations (<xref rid="f0060" ref-type="fig">Fig. A.5</xref>). And since the DMS data are measured indirectly and a systematic error of a measurement may be present, we suggest using non-DMS data for ML model evaluation.</p>
    <p id="p0180">In order not to miss any important factor possibly affecting solubility, we track many conditions of experiments. Yet, several factors known or suspected to influence protein expression or solubility are not stored explicitly in the current version of the database. Some of these factors are silent mutations, i.e., mutations on the nucleotide-sequence level that do not propagate into the amino-acid sequence but may strongly influence soluble expression, especially heterologous <xref rid="b0185" ref-type="bibr">[37]</xref>. Another factor is the time of expression, often not reported clearly, e.g., due to a possible complexity of the assay. Timings of different steps of an experiment may influence soluble expression, for example, through expression rate or by providing a different time for molecular interactions (precipitation, aggregation) <xref rid="b0190" ref-type="bibr">[38]</xref>.</p>
    <p id="p0185">Finally, the database promotes the FAIR principles not only by making the solubility data more accessible but also by allowing negative reporting. Currently, many negative findings in solubility experiments remain unreported as they do not bring the desired outcome to the scientists. We encourage the deposition of negative solubility data in SoluProtMut<sup>DB</sup> to meet the obligations to publish results and reach FAIRness, often imposed by grant agencies. At the same time, these data are of considerable value for the field of ML, even to the extent comparable to that of positive results. Last but not least, non-reporting of negative findings may lead to repeating the same experiments and result in wasting human and material resources. Results of mutational solubility experiments can be sent to soluprot@sci.muni.cz to be deposited in the database.</p>
  </sec>
  <sec id="s0070">
    <title>CRediT authorship contribution statement</title>
    <p id="p0195"><bold>Jan Velecký:</bold> Software, Visualization, Data curation, Writing – original draft, Writing – review &amp; editing. <bold>Marie Hamsikova:</bold> Software, Visualization, Writing – original draft, Writing – review &amp; editing. <bold>Jan Stourac:</bold> Writing – review &amp; editing, Supervision. <bold>Milos Musil:</bold> Software, Writing – original draft. <bold>Jiri Damborsky:</bold> Writing – review &amp; editing, Supervision. <bold>David Bednar:</bold> Writing – review &amp; editing, Supervision. <bold>Stanislav Mazurenko:</bold> Data curation, Writing – review &amp; editing, Supervision.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Declaration of Competing Interest</title>
    <p id="p0190">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
  </sec>
</body>
<back>
  <ref-list id="bi005">
    <title>References</title>
    <ref id="b0005">
      <label>1</label>
      <element-citation publication-type="journal" id="h0005">
        <person-group person-group-type="author">
          <name>
            <surname>Stourac</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Dubrava</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Musil</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Horackova</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Damborsky</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Mazurenko</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Bednar</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>FireProtDB: database of manually curated protein stability data</article-title>
        <source>Nucleic Acids Res</source>
        <volume>49</volume>
        <issue>D1</issue>
        <year>2020</year>
        <fpage>D319</fpage>
        <lpage>D324</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa981</pub-id>
      </element-citation>
    </ref>
    <ref id="b0010">
      <label>2</label>
      <element-citation publication-type="journal" id="h0010">
        <person-group person-group-type="author">
          <name>
            <surname>Kulandaisamy</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sakthivel</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Gromiha</surname>
            <given-names>M.M.</given-names>
          </name>
        </person-group>
        <article-title>MPTherm: database for membrane protein thermodynamics for understanding folding and stability</article-title>
        <source>Briefings Bioinform</source>
        <volume>22</volume>
        <issue>2</issue>
        <year>2020</year>
        <fpage>2119</fpage>
        <lpage>2125</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbaa064</pub-id>
      </element-citation>
    </ref>
    <ref id="b0015">
      <label>3</label>
      <element-citation publication-type="journal" id="h0015">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>D3distalmutation: a database to explore the effect of distal mutations on enzyme activity</article-title>
        <source>J Chem Inf Model</source>
        <volume>61</volume>
        <issue>5</issue>
        <year>2021</year>
        <fpage>2499</fpage>
        <lpage>2508</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.1c00318</pub-id>
        <pub-id pub-id-type="pmid">33938221</pub-id>
      </element-citation>
    </ref>
    <ref id="b0020">
      <label>4</label>
      <element-citation publication-type="journal" id="h0020">
        <person-group person-group-type="author">
          <name>
            <surname>Shire</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Shahrokh</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Challenges in the development of high protein concentration formulations</article-title>
        <source>J Pharm Sci</source>
        <volume>93</volume>
        <issue>6</issue>
        <year>2004</year>
        <fpage>1390</fpage>
        <lpage>1402</lpage>
        <pub-id pub-id-type="doi">10.1002/jps.20079</pub-id>
        <comment>URL <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0022354916315234" id="ir010">https://www.sciencedirect.com/science/article/pii/S0022354916315234</ext-link></comment>
        <pub-id pub-id-type="pmid">15124199</pub-id>
      </element-citation>
    </ref>
    <ref id="b0025">
      <label>5</label>
      <mixed-citation publication-type="other" id="h9001">Vázquez-Rey M., Lang D.A. Aggregates in monoclonal antibody manufacturing processes, Biotechnol Bioeng 108 (7) (2011) 1494–1508, eprint: <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.23155" id="ir121">https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.23155</ext-link>. doi:10.1002/bit.23155. <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1002/bit.23155" id="ir444">https://onlinelibrary.wiley.com/doi/abs/10.1002/bit.23155</ext-link>.</mixed-citation>
    </ref>
    <ref id="b0030">
      <label>6</label>
      <mixed-citation publication-type="other" id="h0030">W. Chen, X. Chen, Z. Hu, H. Lin, F. Zhou, L. Luo, X. Zhang, X. Zhong, Y. Yang, C. Wu, Z. Lin, S. Ye, Y. Liu, F. t. S.G.O. Ccpmoh, A Missense Mutation in CRYBB2 Leads to Progressive Congenital Membranous Cataract by Impacting the Solubility and Function of <inline-formula><mml:math id="M10" altimg="si11.svg"><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:math></inline-formula>B2-Crystallin, PLOS ONE 8 (11) (2013) e81290, publisher: Public Library of Science. doi:10.1371/journal.pone.0081290.<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081290" id="ir015">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081290</ext-link>.</mixed-citation>
    </ref>
    <ref id="b0035">
      <label>7</label>
      <element-citation publication-type="journal" id="h0035">
        <person-group person-group-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Deutsch</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Krishnamoorthy</surname>
            <given-names>B.</given-names>
          </name>
        </person-group>
        <article-title>Scoring function to predict solubility mutagenesis</article-title>
        <source>Algorith Mol Biol</source>
        <volume>5</volume>
        <issue>1</issue>
        <year>2010</year>
        <fpage>33</fpage>
        <pub-id pub-id-type="doi">10.1186/1748-7188-5-33</pub-id>
      </element-citation>
    </ref>
    <ref id="b0040">
      <label>8</label>
      <element-citation publication-type="journal" id="h0040">
        <person-group person-group-type="author">
          <name>
            <surname>Sormanni</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Aprile</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Vendruscolo</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>The camsol method of rational design of protein mutants with enhanced solubility</article-title>
        <source>J Mol Biol</source>
        <volume>427</volume>
        <issue>2</issue>
        <year>2015</year>
        <fpage>478</fpage>
        <lpage>490</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmb.2014.09.026</pub-id>
        <pub-id pub-id-type="pmid">25451785</pub-id>
      </element-citation>
    </ref>
    <ref id="b0045">
      <label>9</label>
      <element-citation publication-type="journal" id="h0045">
        <person-group person-group-type="author">
          <name>
            <surname>Zambrano</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jamroz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Szczasiuk</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Pujols</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kmiecik</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ventura</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>AGGRESCAN3d (a3d): server for prediction of aggregation properties of protein structures</article-title>
        <source>Nucleic Acids Res</source>
        <volume>43</volume>
        <issue>W1</issue>
        <year>2015</year>
        <fpage>W306</fpage>
        <lpage>W313</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv359</pub-id>
        <pub-id pub-id-type="pmid">25883144</pub-id>
      </element-citation>
    </ref>
    <ref id="b0050">
      <label>10</label>
      <element-citation publication-type="journal" id="h0050">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Niroula</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Vihinen</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>PON-sol: prediction of effects of amino acid substitutions on protein solubility</article-title>
        <source>Bioinformatics</source>
        <volume>32</volume>
        <issue>13</issue>
        <year>2016</year>
        <fpage>2032</fpage>
        <lpage>2034</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw066</pub-id>
        <pub-id pub-id-type="pmid">27153720</pub-id>
      </element-citation>
    </ref>
    <ref id="b0055">
      <label>11</label>
      <element-citation publication-type="journal" id="h0055">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Vihinen</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Pon-sol2: Prediction of effects of variants on protein solubility</article-title>
        <source>Int J Mol Sci</source>
        <volume>22</volume>
        <issue>15</issue>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.3390/ijms22158027</pub-id>
        <comment>URL <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/1422-0067/22/15/8027" id="ir020">https://www.mdpi.com/1422-0067/22/15/8027</ext-link></comment>
      </element-citation>
    </ref>
    <ref id="b0060">
      <label>12</label>
      <mixed-citation publication-type="other" id="h9002">Klesmith J.R., Bacik J.-P., Wrenbeck E.E., Michalczyk R., Whitehead T.A. Trade-offs between enzyme fitness and solubility illuminated by deep mutational scanning, Proc of the Natl Acad of Sci USA 114 (9) (2017) 2265–2270. arXiv:<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/content/114/9/2265.full.pdf" id="ir801">https://www.pnas.org/content/114/9/2265.full.pdf</ext-link>, doi:10.1073/pnas.1614437114. <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/content/114/9/2265" id="ir803">https://www.pnas.org/content/114/9/2265</ext-link>.</mixed-citation>
    </ref>
    <ref id="b0065">
      <label>13</label>
      <element-citation publication-type="journal" id="h0065">
        <person-group person-group-type="author">
          <name>
            <surname>Wrenbeck</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Bedewitz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Klesmith</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Noshin</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Barry</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Whitehead</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>An automated data-driven pipeline for improving heterologous enzyme expression</article-title>
        <source>ACS Synthet Biol</source>
        <volume>8</volume>
        <issue>02</issue>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1021/acssynbio.8b00486</pub-id>
      </element-citation>
    </ref>
    <ref id="b0070">
      <label>14</label>
      <element-citation publication-type="book" id="h0070">
        <person-group person-group-type="author">
          <name>
            <surname>Mazurenko</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Prokop</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Damborsky</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <part-title>Machine Learning in Enzyme Engineering</part-title>
        <source>ACS Catal</source>
        <volume>10</volume>
        <year>2020</year>
        <publisher-name>publisher: American Chemical Society</publisher-name>
        <fpage>1210</fpage>
        <lpage>1223</lpage>
        <pub-id pub-id-type="doi">10.1021/acscatal.9b04321</pub-id>
      </element-citation>
    </ref>
    <ref id="b0075">
      <label>15</label>
      <mixed-citation publication-type="other" id="h9003">T.U. Consortium, UniProt: the universal protein knowledgebase in 2021, Nucleic Acids Res 49 (D1) (2020) D480–D489. doi:10.1093/nar/gkaa1100. URL <pub-id pub-id-type="doi">10.1093/nar/gkaa1100</pub-id>.</mixed-citation>
    </ref>
    <ref id="b0080">
      <label>16</label>
      <mixed-citation publication-type="other" id="h9004">Sumbalova L., Stourac J., Martinek T., Bednar D., Damborsky J. HotSpot wizard 3.0: web server for automated design of mutations and smart libraries based on sequence input information, Nucleic Acids Res 46 (W1) (2018) W356–W362. <pub-id pub-id-type="doi">10.1093/nar/gky417</pub-id>.</mixed-citation>
    </ref>
    <ref id="b0085">
      <label>17</label>
      <element-citation publication-type="journal" id="h0085">
        <person-group person-group-type="author">
          <name>
            <surname>Kaur</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements</article-title>
        <source>Int J Biol Macromol</source>
        <volume>106</volume>
        <year>2018</year>
        <fpage>803</fpage>
        <lpage>822</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.08.080</pub-id>
        <pub-id pub-id-type="pmid">28830778</pub-id>
      </element-citation>
    </ref>
    <ref id="b0090">
      <label>18</label>
      <mixed-citation publication-type="other" id="h9005">Slanská K. Study of protein solubility [online] Master’s thesis, Faculty of Science, Masaryk University, Brno (2021). URL Availableat&lt;<ext-link ext-link-type="uri" xlink:href="https://is.muni.cz/th/e3jlf/" id="ir499">https://is.muni.cz/th/e3jlf/</ext-link>&gt;</mixed-citation>
    </ref>
    <ref id="b0095">
      <label>19</label>
      <mixed-citation publication-type="other" id="h9006">Bendl J., Stourac J., Sebestova E., Vavra O., Musil M., Brezovsky J., Damborsky J. HotSpot Wizard 2.0: automated design of site-specific mutations and smart libraries in protein engineering, Nucleic Acids Res 44 (Web Server issue) (2016) W479–W487. doi:10.1093/nar/gkw416. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987947/" id="ir544">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987947/</ext-link>.</mixed-citation>
    </ref>
    <ref id="b0100">
      <label>20</label>
      <element-citation publication-type="journal" id="h0100">
        <person-group person-group-type="author">
          <name>
            <surname>Camacho</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Coulouris</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Avagyan</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Papadopoulos</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bealer</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Madden</surname>
            <given-names>T.L.</given-names>
          </name>
        </person-group>
        <article-title>BLAST+: architecture and applications</article-title>
        <source>BMC Bioinform</source>
        <volume>10</volume>
        <year>2009</year>
        <fpage>421</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-10-421</pub-id>
      </element-citation>
    </ref>
    <ref id="b0105">
      <label>21</label>
      <element-citation publication-type="journal" id="h0105">
        <person-group person-group-type="author">
          <name>
            <surname>Suzek</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>McGarvey</surname>
            <given-names>P.B.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C.H.</given-names>
          </name>
        </person-group>
        <article-title>UniProt Consortium, UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches</article-title>
        <source>Bioinformatics (Oxford, England)</source>
        <volume>31</volume>
        <issue>6</issue>
        <year>2015</year>
        <fpage>926</fpage>
        <lpage>932</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu739</pub-id>
      </element-citation>
    </ref>
    <ref id="b0110">
      <label>22</label>
      <element-citation publication-type="journal" id="h0110">
        <person-group person-group-type="author">
          <name>
            <surname>Edgar</surname>
            <given-names>R.C.</given-names>
          </name>
        </person-group>
        <article-title>Search and clustering orders of magnitude faster than BLAST</article-title>
        <source>Bioinformatics (Oxford, England)</source>
        <volume>26</volume>
        <issue>19</issue>
        <year>2010</year>
        <fpage>2460</fpage>
        <lpage>2461</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq461</pub-id>
      </element-citation>
    </ref>
    <ref id="b0115">
      <label>23</label>
      <element-citation publication-type="journal" id="h0115">
        <person-group person-group-type="author">
          <name>
            <surname>Sievers</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Wilm</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Dineen</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>T.J.</given-names>
          </name>
          <name>
            <surname>Karplus</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>McWilliam</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Remmert</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Söding</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Higgins</surname>
            <given-names>D.G.</given-names>
          </name>
        </person-group>
        <article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega</article-title>
        <source>Mol Syst Biol</source>
        <volume>7</volume>
        <year>2011</year>
        <fpage>539</fpage>
        <pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id>
        <pub-id pub-id-type="pmid">21988835</pub-id>
      </element-citation>
    </ref>
    <ref id="b0120">
      <label>24</label>
      <element-citation publication-type="journal" id="h0120">
        <person-group person-group-type="author">
          <name>
            <surname>Capra</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Predicting functionally important residues from sequence conservation</article-title>
        <source>Bioinformatics (Oxford, England)</source>
        <volume>23</volume>
        <issue>15</issue>
        <year>2007</year>
        <fpage>1875</fpage>
        <lpage>1882</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btm270</pub-id>
      </element-citation>
    </ref>
    <ref id="b0125">
      <label>25</label>
      <element-citation publication-type="journal" id="h0125">
        <person-group person-group-type="author">
          <name>
            <surname>Kabsch</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <article-title>Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features</article-title>
        <source>Biopolymers</source>
        <volume>22</volume>
        <issue>12</issue>
        <year>1983</year>
        <fpage>2577</fpage>
        <lpage>2637</lpage>
        <pub-id pub-id-type="doi">10.1002/bip.360221211</pub-id>
        <pub-id pub-id-type="pmid">6667333</pub-id>
      </element-citation>
    </ref>
    <ref id="b0130">
      <label>26</label>
      <element-citation publication-type="journal" id="h0130">
        <person-group person-group-type="author">
          <name>
            <surname>Shrake</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Rupley</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Environment and exposure to solvent of protein atoms. Lysozyme and insulin</article-title>
        <source>J Mol Biol</source>
        <volume>79</volume>
        <issue>2</issue>
        <year>1973</year>
        <fpage>351</fpage>
        <lpage>371</lpage>
        <pub-id pub-id-type="doi">10.1016/0022-2836(73)90011-9</pub-id>
        <pub-id pub-id-type="pmid">4760134</pub-id>
      </element-citation>
    </ref>
    <ref id="b0135">
      <label>27</label>
      <mixed-citation publication-type="other" id="h9011">Reetz M.T., Carballeira J.D., Vogel A. Iterative Saturation Mutagenesis on the Basis of B Factors as a Strategy for Increasing Protein Thermostability, Angewandte Chem Int Ed 45(46) (2006) 7745–7751, eprint: <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.200602795" id="ir109">https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.200602795</ext-link>. doi:10.1002/anie.200602795. <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.200602795" id="ir456">https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.200602795</ext-link>.</mixed-citation>
    </ref>
    <ref id="b0140">
      <label>28</label>
      <element-citation publication-type="journal" id="h0140">
        <person-group person-group-type="author">
          <name>
            <surname>Le Guilloux</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Schmidtke</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Tuffery</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Fpocket: an open source platform for ligand pocket detection</article-title>
        <source>BMC Bioinform</source>
        <volume>10</volume>
        <year>2009</year>
        <fpage>168</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-10-168</pub-id>
      </element-citation>
    </ref>
    <ref id="b0145">
      <label>29</label>
      <element-citation publication-type="journal" id="h0145">
        <person-group person-group-type="author">
          <name>
            <surname>Chovancova</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Pavelka</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Benes</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Strnad</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Brezovsky</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kozlikova</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Gora</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sustr</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Klvana</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Medek</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Biedermannova</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sochor</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Damborsky</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures</article-title>
        <source>PLoS Comput Biol</source>
        <volume>8</volume>
        <issue>10</issue>
        <year>2012</year>
        <object-id pub-id-type="publisher-id">e1002708</object-id>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1002708</pub-id>
      </element-citation>
    </ref>
    <ref id="b0150">
      <label>30</label>
      <element-citation publication-type="journal" id="h0150">
        <person-group person-group-type="author">
          <name>
            <surname>Velankar</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Dana</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>van Ginkel</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Gane</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Oldfield</surname>
            <given-names>T.J.</given-names>
          </name>
          <name>
            <surname>O’Donovan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>M.-J.</given-names>
          </name>
          <name>
            <surname>Kleywegt</surname>
            <given-names>G.J.</given-names>
          </name>
        </person-group>
        <article-title>SIFTS: Structure integration with function, taxonomy and sequences resource</article-title>
        <source>Nucleic Acids Res</source>
        <volume>41</volume>
        <issue>D1</issue>
        <year>2012</year>
        <fpage>D483</fpage>
        <lpage>D489</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1258</pub-id>
        <pub-id pub-id-type="pmid">23203869</pub-id>
      </element-citation>
    </ref>
    <ref id="b0155">
      <label>31</label>
      <mixed-citation publication-type="other" id="h0155">M.D. Wilkinson, M. Dumontier, I.J. Aalbersberg, G. Appleton, M. Axton, A. Baak, N. Blomberg, J.-W. Boiten, L.B. da Silva Santos, P.E. Bourne, J. Bouwman, A.J. Brookes, T. Clark, M. Crosas, I. Dillo, O. Dumon, S. Edmunds, C.T. Evelo, R. Finkers, A. Gonzalez-Beltran, A.J. Gray, P. Groth, C. Goble, J.S. Grethe, J. Heringa, P.A. ’t Hoen, R. Hooft, T. Kuhn, R. Kok, J. Kok, S.J. Lusher, M.E. Martone, A. Mons, A.L. Packer, B. Persson, P. Rocca-Serra, M. Roos, R. van Schaik, S.-A. Sansone, E. Schultes, T. Sengstag, T. Slater, G. Strawn, M.A. Swertz, M. Thompson, J. van der Lei, E. van Mulligen, J. Velterop, A. Waagmeester, P. Wittenburg, K. Wolstencroft, J. Zhao, B. Mons, The FAIR guiding principles for scientific data management and stewardship, Sci Data 3(1) (Mar. 2016). doi:10.1038/sdata.2016.18. URL <pub-id pub-id-type="doi">10.1038/sdata.2016.18</pub-id>.</mixed-citation>
    </ref>
    <ref id="b0160">
      <label>32</label>
      <element-citation publication-type="journal" id="h0160">
        <person-group person-group-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>L.J.</given-names>
          </name>
          <name>
            <surname>Pundir</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>M.J.</given-names>
          </name>
        </person-group>
        <article-title>the UniProt Consortium, Protvista: visualization of protein sequence annotations</article-title>
        <source>Bioinformatics</source>
        <volume>33</volume>
        <issue>13</issue>
        <year>2017</year>
        <fpage>2040</fpage>
        <lpage>2041</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx120</pub-id>
        <pub-id pub-id-type="pmid">28334231</pub-id>
      </element-citation>
    </ref>
    <ref id="b0165">
      <label>33</label>
      <mixed-citation publication-type="other" id="h9012">Sehnal D., Bittrich S., Deshpande M., Svobodova R., Berka K., Bazgier V., Velankar S., Burley S.K., Koca J., Rose A.S. Mol* viewer: modern web app for 3d visualization and analysis of large biomolecular structures, Nucleic Acids Res 49(W1) (2021) W431–W437. <pub-id pub-id-type="doi">10.1093/nar/gkab314</pub-id>.</mixed-citation>
    </ref>
    <ref id="b0170">
      <label>34</label>
      <element-citation publication-type="journal" id="h0170">
        <person-group person-group-type="author">
          <name>
            <surname>Pucci</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Schwersensky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Rooman</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence challenges for predicting the impact of mutations on protein stability</article-title>
        <source>Curr Opin Struct Biol</source>
        <volume>72</volume>
        <year>2022</year>
        <fpage>161</fpage>
        <lpage>168</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sbi.2021.11.001</pub-id>
        <comment>URL <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0959440X21001445" id="ir035">https://www.sciencedirect.com/science/article/pii/S0959440X21001445</ext-link></comment>
        <pub-id pub-id-type="pmid">34922207</pub-id>
      </element-citation>
    </ref>
    <ref id="b0175">
      <label>35</label>
      <element-citation publication-type="journal" id="h0175">
        <person-group person-group-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>A critical review of five machine learning-based algorithms for predicting protein stability changes upon mutation</article-title>
        <source>Briefings Bioinform</source>
        <volume>21</volume>
        <issue>4</issue>
        <year>2020</year>
        <fpage>1285</fpage>
        <lpage>1292</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbz071</pub-id>
      </element-citation>
    </ref>
    <ref id="b0180">
      <label>36</label>
      <element-citation publication-type="journal" id="h0180">
        <person-group person-group-type="author">
          <name>
            <surname>Sanavia</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Birolo</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Montanucci</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Turina</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Capriotti</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Fariselli</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Limitations and challenges in protein stability prediction upon genome variations: towards future applications in precision medicine</article-title>
        <source>Comput Struct Biotechnol J</source>
        <volume>18</volume>
        <year>2020</year>
        <fpage>1968</fpage>
        <lpage>1979</lpage>
        <pub-id pub-id-type="doi">10.1016/j.csbj.2020.07.011</pub-id>
        <pub-id pub-id-type="pmid">32774791</pub-id>
      </element-citation>
    </ref>
    <ref id="b0185">
      <label>37</label>
      <element-citation publication-type="journal" id="h0185">
        <person-group person-group-type="author">
          <name>
            <surname>Gustafsson</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Govindarajan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Minshull</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Codon bias and heterologous protein expression</article-title>
        <source>Trends Biotechnol</source>
        <volume>22</volume>
        <issue>7</issue>
        <year>2004</year>
        <fpage>346</fpage>
        <lpage>353</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibtech.2004.04.006</pub-id>
        <comment>URL <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0167779904001118" id="ir040">https://www.sciencedirect.com/science/article/pii/S0167779904001118</ext-link></comment>
        <pub-id pub-id-type="pmid">15245907</pub-id>
      </element-citation>
    </ref>
    <ref id="b0190">
      <label>38</label>
      <element-citation publication-type="journal" id="h0190">
        <person-group person-group-type="author">
          <name>
            <surname>Kuroda</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Biophysical studies of protein solubility and amorphous aggregation by systematic mutational analysis and a helical polymerization model</article-title>
        <source>Biophys Rev</source>
        <volume>10</volume>
        <issue>2</issue>
        <year>2018</year>
        <fpage>473</fpage>
        <lpage>480</lpage>
        <pub-id pub-id-type="doi">10.1007/s12551-017-0342-y</pub-id>
        <comment>URL <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899702/" id="ir045">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899702/</ext-link></comment>
        <pub-id pub-id-type="pmid">29302914</pub-id>
      </element-citation>
    </ref>
    <ref id="b0195">
      <label>39</label>
      <element-citation publication-type="journal" id="h0195">
        <person-group person-group-type="author">
          <name>
            <surname>Kozlowski</surname>
            <given-names>L.P.</given-names>
          </name>
        </person-group>
        <article-title>Proteome-pI: proteome isoelectric point database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>45</volume>
        <issue>D1</issue>
        <year>2017</year>
        <fpage>D1112</fpage>
        <lpage>D1116</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw978</pub-id>
        <pub-id pub-id-type="pmid">27789699</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="s0065">
    <label>Appendix A</label>
    <title>Supportive information</title>
    <p id="p0210"><xref rid="f0040" ref-type="fig">Fig. A.1</xref>, <xref rid="f0045" ref-type="fig">Fig. A.2</xref>, <xref rid="f0050" ref-type="fig">Fig. A.3</xref>, <xref rid="f0055" ref-type="fig">Fig. A.4</xref>, <xref rid="f0060" ref-type="fig">Fig. A.5</xref>, <xref rid="f0065" ref-type="fig">Fig. A.6</xref><fig id="f0040"><label>Fig. A.1</label><caption><p>A matrix showing the numbers of mutation occurrences in the database ‘from’ (rows) and ‘to’ (columns) specific amino acids. The <inline-formula><mml:math id="M11" altimg="si3.svg"><mml:mrow><mml:mi mathvariant="normal">Σ</mml:mi></mml:mrow></mml:math></inline-formula> column and row represent the total numbers of mutations ‘from’ and ‘to’ given amino acids, respectively. The matrix is <italic>row-weighted</italic> – blue saturation corresponds to the relative abundance of the given ‘to’ amino acid in the corresponding row. This is to avoid accentuation of differences naturally caused by the uneven distribution of amino acids in natural sequences.</p></caption><graphic xlink:href="gr8"/></fig><fig id="f0045"><label>Fig. A.2</label><caption><p>The histogram of the substituted amino acids in the database. The red bar shows the deviation from the natural distribution of amino acids, as in sequences of all kingdoms of life <xref rid="b0195" ref-type="bibr">[39]</xref>.</p></caption><graphic xlink:href="gr9"/></fig><fig id="f0050"><label>Fig. A.3</label><caption><p>A row-weighted substitution matrix for Whitehead’s data. It shows some anomalies, such as visible under-representation of substitutions to methionine (M) or tryptophan (W).</p></caption><graphic xlink:href="gr10"/></fig><fig id="f0055"><label>Fig. A.4</label><caption><p>A row-weighted substitution matrix for all but Whitehead’s data. It shows the selection bias in the small-scale experiments. For example, alanine (A) or serine (S) is chosen as a substituent more frequently than other amino acids. Some of the biases are apparently due to avoidance of introducing a different functional group by a mutation, e.g., tryptophan (W) is mostly replaced with phenylalanine (F).</p></caption><graphic xlink:href="gr11"/></fig><fig id="f0060"><label>Fig. A.5</label><caption><p>A comparison between the distributions of effects in the non-DMS and DMS-only datasets. The latter is skewed towards mutations having desolubilizing effect.</p></caption><graphic xlink:href="gr12"/></fig><fig id="f0065"><label>Fig. A.6</label><caption><p>An example of the 2nd step of Export Wizard. Here, the solubility effect of all selected entries will be converted into the 2-value system using a best guess, and datapoints will be exported into a CSV file upon clicking on ‘Export’. There is also an option to skip the wizard and export the raw data.</p></caption><graphic xlink:href="gr13"/></fig></p>
  </sec>
  <ack id="ak005">
    <title>Acknowledgments</title>
    <p id="p0240">This work was supported by Czech Ministry of Education, Youth and Sports [INBIO CZ.02.1.01/0.0/0.0/16_026/0008451, CETOCOEN Excellence CZ.02.1.01/0.0/0.0/17_043/0009632, CETOCOEN Plus CZ.02.1.01/0.0/0.0/15_003/0000469, ESFRI RECETOX RI LM2018121, ESFRI ELIXIR LM2018131]; Technology Agency of the Czech Republic [FW03010208]; Brno University of Technology [FIT-S-20–6293 to M.M.]; CETOCOEN EXCELLENCE Teaming 2 project supported by Horizon2020 of the European Union [857560]; National Institute for Cancer Research [LX22NPO5102] funded by EU - Next Generation EU; and Czech Science Foundation [20-15915Y to D.B.].</p>
    <p id="p0200">This publication reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains.</p>
    <p id="p0205">The authors thank the anonymous reviewers for their valuable suggestions.</p>
  </ack>
  <fn-group>
    <fn id="fn1">
      <label>1</label>
      <p id="np005"><ext-link ext-link-type="uri" xlink:href="https://loschmidt.chemi.muni.cz/soluprotmutdb/protein/103" id="ir005">https://loschmidt.chemi.muni.cz/soluprotmutdb/protein/103</ext-link>.</p>
    </fn>
  </fn-group>
</back>
